Average Height Gained From HGH: How Much Taller Can Children Grow With Growth Hormone Therapy?

For parents concerned about their child’s height, one of the most common questions is: How much taller can my child grow with human growth hormone (HGH) therapy?

Growth hormone treatment has been used for decades to help children with certain medical conditions affecting normal growth. Although results vary depending on the child’s diagnosis, age, bone age, and stage of puberty, research shows that appropriately prescribed HGH therapy can improve growth velocity and, in some children, increase final adult height.

Understanding the average height gained from HGH can help parents establish realistic expectations and determine whether a pediatric growth evaluation may be appropriate.

What Is the Average Height Gained From HGH Therapy?

The average height gained from HGH depends heavily on the underlying reason for treatment.

For children with idiopathic short stature (ISS), clinical studies suggest that growth hormone therapy may increase final adult height by approximately 1.5 to 3 inches (4–7.5 cm) compared with predicted or untreated outcomes, although individual responses vary.

A systematic review published in The BMJ found that children with idiopathic short stature treated with growth hormone achieved an average adult-height improvement of approximately 4 cm compared with untreated children.

Children with confirmed growth hormone deficiency may experience more substantial improvements in growth velocity, particularly during their first year of treatment. However, the eventual increase in adult height depends on the severity of the deficiency, treatment timing, adherence, and other clinical factors.

It is important to distinguish between two measurements:

1. Annual growth velocity: How many inches a child grows during a particular year.
2. Final adult height gain: The additional height a child ultimately achieves because of treatment compared with their expected outcome without therapy.

A child growing four inches during treatment has not necessarily gained four additional inches of final adult height.

How Much Can a Child Grow During the First Year of HGH?

The first year of growth hormone treatment often produces the most noticeable acceleration in growth.

Children with growth hormone deficiency may achieve first-year growth velocities of approximately 8–12 centimeters (3.1–4.7 inches), although responses vary considerably.

For comparison, many healthy prepubertal children older than five grow approximately 5–6 centimeters (2–2.4 inches) annually.

Growth measurement	Approximate annual growth
Typical prepubertal growth	2–2.4 inches
First year of HGH in some children with GHD	3.1–4.7 inches
Subsequent years of HGH treatment	Variable; often slower than the first year

These figures represent general patterns rather than guaranteed results. Children with idiopathic short stature may respond differently from children with confirmed growth hormone deficiency.

Does HGH Increase Final Adult Height?

Yes. Growth hormone therapy can increase final adult height in appropriately selected children, but the magnitude of improvement differs by diagnosis.

For children with growth hormone deficiency, replacing insufficient growth hormone can help restore more normal growth patterns. Some children experience substantial catch-up growth when treatment begins early enough.

For children with idiopathic short stature, average adult-height gains tend to be more modest.

Several factors influence the eventual outcome:

1. Age When Treatment Begins

Children who begin treatment with several years of growth remaining generally have a greater opportunity to benefit than children who begin near the end of puberty.

2. Bone Age and Growth Plate Status

Bone age provides information about skeletal maturity and remaining growth potential.

A child whose bone age is delayed relative to chronological age may have more time remaining for growth. However, delayed bone age does not automatically mean HGH treatment is necessary.

Once the growth plates have fused, HGH will not increase long-bone length or adult height.

3. Underlying Growth Condition

Children with confirmed growth hormone deficiency often respond differently from children with idiopathic short stature, constitutional growth delay, or other causes of short stature.

4. Puberty and Hormonal Development

Puberty plays an important role in growth velocity and growth plate maturation.

Children approaching skeletal maturity may have less time to benefit from treatment, even when growth hormone levels are abnormal.

5. Treatment Adherence and Medical Monitoring

Consistent administration, appropriate dosing, adequate nutrition, and regular follow-up appointments can influence treatment outcomes.

Pediatric endocrinology specialists commonly monitor growth velocity, IGF-1 levels, bone age, thyroid function, and other clinical indicators.

How Long Does HGH Take to Show Height Results?

Parents may notice changes in growth velocity within the first several months of treatment, although meaningful assessment generally requires repeated height measurements over time.

First 3–6 months: Clinicians evaluate early treatment response, medication adherence, and growth trends.

6–12 months: Changes in annualized growth velocity become easier to assess, and clinicians may determine whether treatment is producing an appropriate response.

Years 2 and beyond: Growth commonly continues, but the rate may decrease compared with the first treatment year.

Near skeletal maturity: Treatment is reassessed based on remaining growth potential, diagnosis, and clinical guidelines.

For many children, growth hormone therapy is a multiyear treatment rather than a short-term intervention.

Can HGH Help a 12-, 13-, or 14-Year-Old Grow Taller?

Growth hormone therapy may still be beneficial for some adolescents, but chronological age alone cannot determine eligibility or likely results.

For example, two 13-year-old boys may have significantly different growth potential.

One may have a bone age of 11 years and considerable skeletal growth remaining, while another may have a bone age of 15 years and be approaching growth plate closure.

Similarly, a 12-year-old girl who has progressed substantially through puberty may have less remaining growth potential than another girl of the same age who has not yet entered puberty.

This is why clinicians often recommend a bone age X-ray when evaluating children with unusually slow growth or short stature.

How Do Doctors Determine Whether a Child Needs HGH?

Not every child who is shorter than classmates needs growth hormone treatment.

A comprehensive pediatric growth evaluation may include:

1. Reviewing the child’s height percentile and historical growth velocity.
2. Comparing height with parental heights and genetic expectations.
3. Assessing pubertal development.
4. Obtaining a left-hand and wrist bone age X-ray.
5. Measuring IGF-1 and, when appropriate, IGFBP-3.
6. Screening for thyroid disorders, nutritional deficiencies, celiac disease, and other causes of poor growth.
7. Performing growth hormone stimulation testing when clinically indicated.

Parents seeking additional information about pediatric growth hormone evaluations and treatment options can explore educational resources from HGH for Children, which focuses on helping families better understand childhood growth concerns and available evaluation pathways.

A proper evaluation can help distinguish children who may benefit from medical treatment from those experiencing a normal variation in growth.

What Are the Risks of HGH Therapy in Children?

Growth hormone therapy is generally well tolerated when appropriately prescribed and monitored, but it is not without risks.

Potential adverse effects include headaches, swelling, joint discomfort, changes in glucose metabolism, and injection-site reactions.

Less common but clinically important complications include intracranial hypertension and slipped capital femoral epiphysis (SCFE), a hip disorder that may present with hip, thigh, or knee pain and limping.

Children with certain active malignancies or other contraindications should not receive growth hormone therapy.

Treatment decisions should involve an individualized discussion of potential benefits, risks, monitoring requirements, and realistic height expectations with a qualified pediatric specialist.

Frequently Asked Questions About Average HGH Height Gains

Can HGH make a child 4 inches taller?

Some children experience four or more inches of total growth during a treatment year, particularly when they have significant growth hormone deficiency. However, this does not mean treatment will add four inches to their eventual adult height. The additional adult-height gain varies considerably.

What is the average height increase from HGH in one year?

Some children with growth hormone deficiency grow approximately 3–5 inches during their first treatment year. Children with other diagnoses may experience smaller increases. Actual growth depends on age, puberty, diagnosis, and treatment response.

Does HGH work better before puberty?

Treatment often offers more opportunity for height improvement when initiated before advanced skeletal maturation. However, benefits depend on the underlying diagnosis, and earlier treatment is not automatically appropriate for every short child.

Can HGH increase height after growth plates close?

No. Once the growth plates have fused, growth hormone therapy cannot increase long-bone length or make a person taller.

Is HGH effective for children without growth hormone deficiency?

Growth hormone is approved in the United States for certain pediatric growth conditions beyond classic growth hormone deficiency, including qualifying cases of idiopathic short stature. The expected benefits, treatment criteria, and risks differ by condition.

Final Thoughts: What Height Gain Should Parents Realistically Expect?

The average height gained from HGH is not the same for every child.

Research suggests that children with idiopathic short stature may gain approximately 1.5–3 additional inches of adult height on average, while children with growth hormone deficiency may experience substantial improvements in growth velocity and, depending on their circumstances, final height.

The most important factors are the child’s diagnosis, growth history, bone age, pubertal development, and remaining growth potential.

For parents concerned that their child is growing unusually slowly, obtaining an appropriate medical evaluation is more valuable than relying on general height-gain averages.

Early identification of a genuine growth disorder can provide families with more time to understand their options and make informed treatment decisions.

Medical References

1. Deodati A, Cianfarani S. Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review. BMJ. 2011;342
2. Grimberg A, et al. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents. Hormone Research in Paediatrics. 2016;86(6):361–397.
3. U.S. Food and Drug Administration. Somatropin prescribing information and pediatric indications.
4. Pediatric Endocrine Society. Patient education resources on growth hormone deficiency and short stature.